📰 Two Phase News
Page 7 - Two Phase News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Two Phase. Real-time updates on events, politics, business and more.
March 28, 2022
The first lockdown phase was in effect from 05:00 a.m. local time and will last until 05:00 am April 1 in the areas located east and south of the Huangpu River.
February 6, 2022
Revolo Biotherapeutics Receives MHRA Approval for Two Phase 2 Clinical Trials of ‘1805 in Autoimmune Diseases in the United Kingdom
January 8, 2022
The Election Commission on Saturday announced poll dates for five states with Uttar Pradesh going for seven-phase assembly election from February 10, Manipur to go for two-phase election from February 27 and Punjab, Goa and Uttarakhand to face elections on Februrary 14.
December 9, 2021
RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication - read this article along with other careers information, tips and advice on BioSpace
December 9, 2021
RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori - read this article along with other careers information, tips and advice on BioSpace
December 9, 2021
Investegate announcements from RedHill Biopharma, Concerning Clarithromycin Rx Rates for H. pylori
November 1, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation.
November 1, 2021
ABBVie today announced the presentation of new data on RINVOQ ® SKYRIZI ® and HUMIRA ® across multiple rheumatic diseases at the American College of Rheumatology's annual meeting to be held virtually Nov. 3-9 . A total of 38 abstracts, including two oral presentations and one plenary session presentation, will be presented from a broad range of studies in rheumatoid arthritis, psoriatic arthritis and ankylosing ...
November 1, 2021
/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the presentation of new data on RINVOQ® (upadacitinib), SKYRIZI® (risankizumab) and HUMIRA® (adalimumab)...
October 25, 2021
/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced the presentation of...